StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.36−0.16 (-10.60%)

Close on Nov 19, 2026Market cap $766.14KP/E –Yield –

Universe Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $6.30B, up 3.8% from the year before. The highest annual figure on record is $10.32B in fiscal 2023.

Annual gross profit

PeriodPeriod endValueChange
FY2025Sep 30, 2025$6.30B+3.8%
FY2024Sep 30, 2024$6.07B-41.1%
FY2023Sep 30, 2023$10.32B+47019.7%
FY2022Sep 30, 2022$21.89M-13.6%
FY2021Sep 30, 2021$25.33M+79.7%
FY2020Sep 30, 2020$14.09M+5.1%
FY2019Sep 30, 2019$13.41M–

More Universe Pharmaceuticals figures

See a number that looks wrong?